The availability of a four-in-one respiratory virus diagnostic for home use may be a boon to consumers, but some clinicians say it should not be used as a substitute for a physician’s guidance. The ...

The COVID-19 pandemic yielded important advances in testing for respiratory viruses, but it also exposed important unmet needs in screening to prevent the spread of infections in high-risk settings.

KAIST and international collaborators have created a CRISPR-based diagnostic that uses reaction speed patterns to identify multiple viruses and variants in a single test. The method, called kinetic ...